Quality Attributes of Furosemide Syrup Compounded at Bugando Medical Centre Compounding Unit in Mwanza, Tanzania (Record no. 22178)

MARC details
000 -LEADER
fixed length control field 02419nam a22001697a 4500
001 - CONTROL NUMBER
control field CUHAS/BP/3000444/T/17
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 211210b |||||||| |||| 00| 0 eng d
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Elisha F Msigwa
Dates associated with a name CUHAS/BP/3000444/T/17
9 (RLIN) 26668
Relator term Undergraduate Ethical Clearance Certificate Certificate No. 1830/2021
245 ## - TITLE STATEMENT
Title Quality Attributes of Furosemide Syrup Compounded at Bugando Medical Centre Compounding Unit in Mwanza, Tanzania
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Mwanza, Tanzania:
Name of publisher, distributor, etc. Catholic University of Health and Allied Sciences [CUHAS - Bugando] :
-- Phone: +255 28 298 3384 :
-- Fax: +255 28 298 3386
-- Email: vc@bugando.ac.tz
-- Website: www.bugando.ac.tz :
Date of publication, distribution, etc. ©09 September 2021
300 ## - PHYSICAL DESCRIPTION
Extent xi; 25 Pages
Extent Includes References and Appendices
520 ## - SUMMARY, ETC.
Summary, etc. Abstract:<br/><br/>Background: Furosemide is a potent loop diuretic used in the treatment of oedematous states associated with cardiac, renal and hepatitis failure, and for the treatment of hypertension. In Tanzania Furosemide is a diuretic indicated for the treatment of hypertension. The use of Furosemide at high doses greater than 80mg per day leads high risk of hypokalemia, mild decrease in total thyroid hormone, dehydration, reduced blood volume, electrolyte imbalance. <br/><br/>Methodology: Microbial load determination test and assay test were the laboratory procedures conducted to the triplicate samples to assess the quality of Furosemide syrup for day 1, day 7 and day 14 at Tanzania Medical Devices and Drug Authority laboratories in Mwanza, Tanzania. <br/><br/>Results and Discussion: For the assay test the concentration of compounded furosemide syrup within its shelf life for all the days including day 1, day 7 and 14 were with slight variations but within the required range for its activity. For the microbial load determination test the compounded Furosemide syrup sample for day 1 and day 7 were all negative for both E. coli and P. aeruginosa but for day 14 compounded Furosemide syrup sample tested positive for P. aeruginosa. <br/><br/>Conclusion: The results that compounded Furosemide syrup passed assay test for all the days, day 1, day 7 and 14 but for the microbial load determination test compounded Furosemide syrup passed on day 1 and day 7 but failed the test on day 14 due to P. aeruginosa contamination hence making it not safe for use on day 14. <br/>
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
General subdivision Pharmacy
9 (RLIN) 26693
700 ## - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 26669
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type UNDERGRADUATE DISSERTATIONS
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection Home library Current library Shelving location Date acquired Total checkouts Barcode Date last seen Price effective from Koha item type
            MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO   12/10/2021   UD2440 12/10/2021 12/10/2021 UNDERGRADUATE DISSERTATIONS
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024